Researcher, Douglas Institute
serge_dot_gauthier_At_mcgill_dot_ca |
2014
Belleville S., Gauthier S., Lepage E., Kergoat M. J., Gilbert B. (2014). Predicting decline in mild cognitive impairment: a prospective cognitive study, Neuropsychology, 28(4), 643-52. Find out more.
Dubois B., Feldman H. H., Jacova C., Hampel H., Molinuevo J. L., Blennow K., DeKosky S. T., Gauthier S., Selkoe D., Bateman R., Cappa S., Crutch S., Engelborghs S., Frisoni G. B., Fox N. C., Galasko D., Habert M. O., Jicha G. A., Nordberg A., Pasquier F., Rabinovici G., Robert P., Rowe C., Salloway S., Sarazin M., Epelbaum S., de Souza L. C., Vellas B., Visser P. J., Schneider L., Stern Y., Scheltens P., Cummings J. L. (2014). Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, 13(6), 614-29. Find out more.
Gauthier S., Leuzy A., Rosa-Neto P. (2014). How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?, Neurodegener Dis, 13(2-3), 197-9. Find out more.
Hye A., Riddoch-Contreras J., Baird A. L., Ashton N. J., Bazenet C., Leung R., Westman E., Simmons A., Dobson R., Sattlecker M., Lupton M., Lunnon K., Keohane A., Ward M., Pike I., Zucht H. D., Pepin D., Zheng W., Tunnicliffe A., Richardson J., Gauthier S., Soininen H., Kloszewska I., Mecocci P., Tsolaki M., Vellas B., Lovestone S. (2014). Plasma proteins predict conversion to dementia from prodromal disease, Alzheimers Dement. Find out more.
Jia J., Zhou A., Wei C., Jia X., Wang F., Li F., Wu X., Mok V., Gauthier S., Tang M., Chu L., Zhou Y., Zhou C., Cui Y., Wang Q., Wang W., Yin P., Hu N., Zuo X., Song H., Qin W., Wu L., Li D., Jia L., Song J., Han Y., Xing Y., Yang P., Li Y., Qiao Y., Tang Y., Lv J., Dong X. (2014). The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese, Alzheimers Dement, 10(4), 439-47. Find out more.
Leuzy A., Zimmer E. R., Bhat V., Rosa-Neto P., Gauthier S. (2014). Imaging biomarkers for amyloid: a new generation of probes and what lies ahead, Int Psychogeriatr, 26(5), 703-7. Find out more.
Leuzy A., Zimmer E. R., Heurling K., Rosa-Neto P., Gauthier S. (2014). Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues, Amyloid, 21(3), 143-8. Find out more.
Petersen R. C., Caracciolo B., Brayne C., Gauthier S., Jelic V., Fratiglioni L. (2014). Mild cognitive impairment: a concept in evolution, J Intern Med, 275(3), 214-28. Find out more.
Poirier J., Gauthier S. (2014). Alzheimer’s disease. The Complete Introduction, .
Robert P. H., Konig A., Amieva H., Andrieu S., Bremond F., Bullock R., Ceccaldi M., Dubois B., Gauthier S., Kenigsberg P. A., Nave S., Orgogozo J. M., Piano J., Benoit M., Touchon J., Vellas B., Yesavage J., Manera V. (2014). Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty, Front Aging Neurosci, 6, 54. Find out more.
Schoemaker D., Gauthier S., Pruessner J. (2014). Recollection and familiarity in aging individuals with mild cognitive impairment and Alzheimer's disease: a literature review, Neuropsychol Rev, 24(3), 313-31. Find out more.
Tourian L., Margolese H. C., Gauthier S. (2014). Donepezil-Associated Mania in 2 Patients who Were Using Donepezil Without a Prescription, J Clin Psychopharmacol. Find out more.
Vellas B., Sampaio C., Bateman R., Boxer A., Carrillo MC., Cummings J., Dubois B., Hampel H., Katz R., Khachaturian Z., Gauthier S., Johnson K., Karlawish J., Mintun M., Petersen R., Rafii M., Robert P., Schneider LS., Siemers E., Sperling R., Tariot P., Touchon J., Weiner M., Andrieu S., Aisen P., Task Force Members (2014). E.U./U.S. CTAD Task Force on Alzheimer's Trial Populations, J Prev Alz Dis, 1(2), 110-116.
Wimo A., Ballard C., Brayne C., Gauthier S., Handels R., Jones R. W., Jonsson L., Khachaturian A. S., Kramberger M. (2014). Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria, J Intern Med, 275(3), 304-16. Find out more.
Wu L., Soder R. B., Schoemaker D., Carbonnell F., Sziklas V., Rowley J., Mohades S., Fonov V., Bellec P., Dagher A., Shmuel A., Jia J., Gauthier S., Rosa-Neto P. (2014). Resting state executive control network adaptations in amnestic mild cognitive impairment, J Alzheimers Dis, 40(4), 993-1004. Find out more.
Zimmer E. R., Leuzy A., Benedet A. L., Breitner J., Gauthier S., Rosa-Neto P. (2014). Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging, J Neuroinflammation, 11, 120. Find out more.
Zimmer E. R., Leuzy A., Bhat V., Gauthier S., Rosa-Neto P. (2014). In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals, Transl Neurodegener, 3(1), 6. Find out more.
Zimmer E. R., Leuzy A., Gauthier S., Rosa-Neto P. (2014). Developments in Tau PET Imaging, Can J Neurol Sci, 41(5), 547-53. Find out more.
Zimmer E. R., Parent M. J., Cuello A. C., Gauthier S., Rosa-Neto P. (2014). MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research, Trends Neurosci. Find out more.